Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 3
1984 1
1985 2
1986 5
1987 4
1988 3
1989 7
1990 3
1991 7
1992 4
1993 1
1994 6
1995 6
1996 13
1997 8
1998 12
1999 2
2000 7
2001 14
2002 10
2003 10
2004 11
2005 12
2006 12
2007 14
2008 13
2009 10
2010 18
2011 10
2012 14
2013 13
2014 12
2015 14
2016 10
2017 9
2018 9
2019 10
2020 9
2021 13
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

307 results
Results by year
Filters applied: . Clear all
Page 1
Immunosuppression for the Uveitides.
Jabs DA. Jabs DA. Ophthalmology. 2018 Feb;125(2):193-202. doi: 10.1016/j.ophtha.2017.08.007. Epub 2017 Sep 20. Ophthalmology. 2018. PMID: 28942074 Free PMC article. Review.
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis.
Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study Consensus Group. Agrawal R, et al. Among authors: jabs da. Ophthalmology. 2021 Feb;128(2):266-276. doi: 10.1016/j.ophtha.2020.01.008. Epub 2020 Jan 11. Ophthalmology. 2021. PMID: 32115264
Cidofovir.
Jabs DA. Jabs DA. Arch Ophthalmol. 1997 Jun;115(6):785-6. doi: 10.1001/archopht.1997.01100150787016. Arch Ophthalmol. 1997. PMID: 9194731 Review. No abstract available.
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA; Multicenter Uveitis Steroid Treatment Trial Research Group. Thorne JE, et al. Among authors: jabs da. Ophthalmology. 2019 Feb;126(2):283-295. doi: 10.1016/j.ophtha.2018.08.021. Epub 2018 Sep 27. Ophthalmology. 2019. PMID: 30269924 Free PMC article. Clinical Trial.
Uveitis for the non-ophthalmologist.
Burkholder BM, Jabs DA. Burkholder BM, et al. Among authors: jabs da. BMJ. 2021 Feb 3;372:m4979. doi: 10.1136/bmj.m4979. BMJ. 2021. PMID: 33536186 Review.
Immunosuppression for posterior uveitis.
Jabs DA, Akpek EK. Jabs DA, et al. Retina. 2005 Jan;25(1):1-18. doi: 10.1097/00006982-200501000-00001. Retina. 2005. PMID: 15655435 Review. No abstract available.
Epidemiology of uveitis.
Jabs DA. Jabs DA. Ophthalmic Epidemiol. 2008 Sep-Oct;15(5):283-4. doi: 10.1080/09286580802478724. Ophthalmic Epidemiol. 2008. PMID: 18850463 No abstract available.
Ocular manifestations of vasculitis.
Thorne JE, Jabs DA. Thorne JE, et al. Among authors: jabs da. Rheum Dis Clin North Am. 2001 Nov;27(4):761-79, vi. doi: 10.1016/s0889-857x(05)70234-9. Rheum Dis Clin North Am. 2001. PMID: 11723763 Review.
307 results